Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
64.29
-0.33 (-0.51%)
At close: Sep 8, 2026, 4:00 PM EDT
64.38
+0.09 (0.14%)
After-hours: Sep 8, 2026, 7:59 PM EDT
Tempus AI Revenue
Tempus AI had revenue of $382.49M in the quarter ending June 30, 2026, with 21.56% growth. This brings the company's revenue in the last twelve months to $1.43B, up 50.43% year-over-year. In the year 2025, Tempus AI had annual revenue of $1.27B with 83.41% growth.
Revenue (ttm)
$1.43B
Revenue Growth
+50.43%
P/S Ratio
8.10
Revenue / Employee
$376,847
Employees
3,800
Market Cap
11.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.27B | 578.39M | 83.41% |
| Dec 31, 2024 | 693.40M | 161.58M | 30.38% |
| Dec 31, 2023 | 531.82M | 211.15M | 65.85% |
| Dec 31, 2022 | 320.67M | 62.82M | 24.36% |
| Dec 31, 2021 | 257.85M | 69.85M | 37.15% |
| Dec 31, 2020 | 188.00M | 125.95M | 202.95% |
| Dec 31, 2019 | 62.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 14.37B |
| Veeva Systems | 3.46B |
| Privia Health Group | 2.36B |
| HealthEquity | 1.36B |
| Omnicell | 1.25B |
| Waystar Holding | 1.21B |
| Hinge Health | 720.06M |
| Doximity | 655.57M |
TEM News
- 18 hours ago - Tempus AI initiated with a Neutral at Rothschild & Co Redburn - TheFly
- 4 days ago - Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
- 6 days ago - Why Moderna's Cancer Vaccine Matters to Investors - ETF Trends
- 6 days ago - Cantor Fitzgerald bullish on Tempus AI, initiates with an Overweight - TheFly
- 6 days ago - Tempus AI initiated with an Overweight at Cantor Fitzgerald - TheFly
- 7 days ago - Tempus AI upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 13 days ago - Top Performing Leveraged/Inverse ETFs: 08/23/2026 - ETF Trends
- 15 days ago - Tempus AI receives FDA clearance for Tempus ECG-PH - TheFly